France
YSOPIA Bioscience is a clinical-stage biotech company founded in 2010 and positioned as the leading biotech in the development of innovative microbiome-based biotherapies. The company's slogan "Leading biotech in the development of innovative microbiome-based biotherapies" embodies its commitment to pioneering advancements in the healthcare and biotechnology industries. YSOPIA Bioscience is dedicated to leveraging the potential of the gut microbiome to develop cutting-edge biotherapies that address unmet medical needs.
Specializing in biotechnology, health care, and health and wellness, YSOPIA Bioscience is poised to disrupt the field with its pursuit of safe and efficient solutions for patients. Although specific details about the headquarters and last investment are not available at present, the company's focus on advancing biotherapies indicates a promising trajectory for potential investors and partners seeking opportunities in the biotech sector.
